Takako Nakano-Yokomizo
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.
Journal: Blood
Published: October 16, 2025
Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.
Journal: Blood
Published: October 16, 2025
Niche-targeted therapy via YAP/TAZ activation enhances hematopoietic regeneration.
Journal: Blood
Published: July 15, 2025
Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs.
Journal: The Journal of experimental medicine
Published: June 03, 2022
YAP1/TAZ activity maintains vascular integrity and organismal survival.
Journal: Biochemical and biophysical research communications
Published: May 23, 2022
CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma.
Journal: Communications biology
Published: January 19, 2022
The acidic domain of Hmga2 and the domain's linker region are critical for driving self-renewal of hematopoietic stem cell.
Journal: International journal of hematology
Published: October 27, 2021
Two faces of RUNX3 in myeloid transformation.
Journal: Experimental hematology
Published: January 01, 2021
Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation.
Journal: Oncogene
Published: June 12, 2020
Last Updated: 09/26/2026